Patents by Inventor Richard Janeczko

Richard Janeczko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ANTIBIOTIC SUSCEPTIBILITY TESTING OF BLOOD SAMPLES
    Publication number: 20220315976
    Abstract: The present disclosure relates to a method for determining the susceptibility of a microorganism to an antimicrobial agent. In particular, to a method for testing the antimicrobial susceptibility of blood samples in patients with a suspected bloodstream infection. In one aspect, for example, the method comprises the steps of: (a) incubating a first blood culture derived from the blood sample; (b) terminating the incubation of the first blood culture after a period of up to about 20 hours from commencement of Step (a) to produce an incubated culture; and (c) performing a molecular phenotypic antimicrobial susceptibility test (AST) assay on the incubated culture to determine the antimicrobial susceptibility of a microorganism.
    Type: Application
    Filed: July 28, 2020
    Publication date: October 6, 2022
    Inventors: Colin Wynn Halford, Scott Adam Churchman, Richard Janeczko
  • IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
    Publication number: 20220034904
    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic. Antibodies produced from an immune response against SARS-CoV-2 infection are used to analyze prior exposure to the virus. The present invention provides methods for detecting antibodies in response to SARS-CoV-2 infection in a single multiplex immunoassay.
    Type: Application
    Filed: September 7, 2021
    Publication date: February 3, 2022
    Inventors: Sandeep Kumar Vashist, Lionel Gilles Guiffo Djoko, Bhavesh Govind, Richard Janeczko
  • Method of detecting mutations associated with thrombosis
    Patent number: 7879543
    Abstract: The present invention provides a method for the simultaneous identification of two or more single base changes in a plurality of target nucleotide sequences that are markers associated with cardiovascular diseases such as deep vein thrombosis and the like. Multiplex detection is accomplished using multiplexed tagged allele specific primer extension (ASPE) and hybridization of such extended primers to a probe, preferably an addressable anti-tagged support.
    Type: Grant
    Filed: November 17, 2004
    Date of Patent: February 1, 2011
    Assignee: Luminex Molecular Diagnostics, Inc.
    Inventors: Susan Bortolin, Frank Merante, Daniel Kobler, Daniel Fieldhouse, Margot Boszko, Hemanshu Modi, Richard A. Janeczko, Roman Zastawny
  • Method of detecting mutations associated with thrombosis
    Publication number: 20070160992
    Abstract: The present invention provides a method for the simultaneous identification of two or more single base changes in a plurality of target nucleotide sequences that are markers associated with cardiovascular diseases such as deep vein thrombosis and the like.
    Type: Application
    Filed: November 17, 2004
    Publication date: July 12, 2007
    Applicant: TM BIOSCIENCE CORPORATION
    Inventors: Susan Bortolin, Frank Merante, Daniel Kobler, Daniel Fieldhouse, Margot Boszko (neeBlack), Hemanshu Modi, Richard Janeczko, Roman Zastawny
  • Polynucleotides for use as tags and tag complements in the detection of nucleic acid sequences
    Publication number: 20050186573
    Abstract: A family of minimally cross-hybridizing nucleotide sequences and their use in the detection of nucleic acid sequences is described. Specifically described is the use of two distinct families of 210 and 1168 24mers in the detection of nucleic acid sequences.
    Type: Application
    Filed: July 24, 2003
    Publication date: August 25, 2005
    Inventor: Richard Janeczko